BackgroundCheck.run
Search For

Jason S Park, 36123 Ames Ave, Leonia, NJ 07605

Known as:
Jaesun Park
Related to:
Sun J Park 56 Jaehoon Hoon Jeong 60

Jason Park Phones & Addresses

Leonia, NJ   

Englewood, NJ   

New York, NY   

Fort Lee, NJ   

Rochester, NY   

Englewd Clfs, NJ   

Ranks

Licence: Dist. of Columbia - Active Date: 2012
Get Report
Control this profile

Mentions for Jason S Park

Career records & work history

Lawyers & Attorneys

Jason Park Photo 1

Jason Park - Lawyer

Address:
646-2479522 (Office)
Licenses:
Dist. of Columbia - Active 2012
Jason Park Photo 2

Jason Park - Lawyer

Specialties:
Litigation
ISLN:
922022303
Admitted:
2008
University:
Princeton University, B.A., 2002
Law School:
Georgetown University Law Center, J.D., 2006
Jason Park Photo 3

Jason Park - Lawyer

Specialties:
Criminal Law, Insurance Law, Litigation, Admiralty & Maritime, Antitrust & Trade Law, Bankruptcy & Debt, Corporate & Incorporation
ISLN:
921826483
Admitted:
2003
Law School:
Brooklyn Law School, J.D.
Jason Park Photo 4

Jason Park - Lawyer

Office:
Devine Park LLP
Specialties:
Development Zoning and Planning, Real Estate
ISLN:
920121328
Admitted:
2000
University:
University of Toronto, 1995
Law School:
University of Western Ontario, LL.B., 1998

Medicine Doctors

Jason Park Photo 5

Dr. Jason S Park, Orangeburg NY - MD (Doctor of Medicine)

Specialties:
Psychiatry
Other
Address:
140 Old Orangeburg Rd, Orangeburg, NY 10962
845-3591000 (Phone) 845-3593143 (Fax)
Languages:
English
Education:
Medical School
Korea University / College of Medicine
Medical School
Utica Psychology Center
Jason Park Photo 6

Dr. Jason Park, New York NY - MD (Doctor of Medicine)

Specialties:
Complex General Surgical Oncology
Address:
1275 York Ave, New York, NY 10065
212-6392000 (Phone)
Languages:
English
Hospitals:
1275 York Ave, New York, NY 10065
Memorial Sloan - Kettering Cancer Center
1275 York Avenue, New York, NY 10065

Jason C. Park

Specialties:
Orthopaedic Surgery
Work:
Holston Medical GroupHolston Medical Group Orthopedics
105 W Stone Dr STE V, Kingsport, TN 37660
423-5781570 (phone) 423-3926251 (fax)
Site
Education:
Medical School
Wayne State University School of Medicine
Graduated: 2002
Procedures:
Hip Replacement, Hip/Femur Fractures and Dislocations, Knee Arthroscopy, Knee Replacement, Lower Arm/Elbow/Wrist Fractures and Dislocations, Lower Leg/Ankle Fractures and Dislocations, Shoulder Arthroscopy, Shoulder Surgery, Arthrocentesis, Carpal Tunnel Decompression, Hallux Valgus Repair, Joint Arthroscopy, Lower Leg Amputation, Wound Care
Conditions:
Lateral Epicondylitis, Fractures, Dislocations, Derangement, and Sprains, Hallux Valgus, Internal Derangement of Knee, Internal Derangement of Knee Cartilage, Intervertebral Disc Degeneration, Osteoarthritis, Osteomyelitis, Osteoporosis, Plantar Fascitis, Rheumatoid Arthritis, Rotator Cuff Syndrome and Allied Disorders, Sciatica, Scoliosis or Kyphoscoliosis, Spinal Stenosis
Languages:
English
Description:
Dr. Park graduated from the Wayne State University School of Medicine in 2002. He works in Kingsport, TN and specializes in Orthopaedic Surgery. Dr. Park is affiliated with Holston Valley Medical Center and Indian Path Medical Center.

Jason A. Park

Specialties:
General Surgery
Work:
Acute Care Surgery Medical GrpAcute Care Surgery Medical Group
2800 L St STE 200, Sacramento, CA 95816
916-4546522 (phone) 916-4546523 (fax)
Site
Education:
Medical School
University of California, Davis School of Medicine
Graduated: 1995
Procedures:
Appendectomy, Endoscopic Retrograde Cholangiopancreatography (ERCP), Laparoscopic Gallbladder Removal, Small Bowel Resection, Spleen Surgey, Tracheostomy, Gallbladder Removal, Hernia Repair, Laparoscopic Appendectomy, Pilonidal Cyst Excision, Upper Gastrointestinal Endoscopy
Conditions:
Appendicitis, Cholelethiasis or Cholecystitis, Intestinal Obstruction, Ventral Hernia, Abdominal Hernia, Breast Disorders, Gastric Cancer, Gastrointestinal Hemorrhage, Inguinal Hernia, Ischemic Bowel Disease, Malignant Neoplasm of Colon, Overweight and Obesity
Languages:
English
Description:
Dr. Park graduated from the University of California, Davis School of Medicine in 1995. He works in Sacramento, CA and specializes in General Surgery. Dr. Park is affiliated with Mercy San Juan Medical Center and Sutter Medical Center Sacramento.

Jason Park

Specialties:
Clinical Pathology
Work:
Childrens Medical Center Pathology
1935 Medical District Dr STE B2280, Dallas, TX 75235
214-4562322 (phone) 214-4560779 (fax)
Education:
Medical School
Thomas Jefferson University, Jefferson Medical College
Graduated: 2003
Languages:
English, Spanish
Description:
Dr. Park graduated from the Thomas Jefferson University, Jefferson Medical College in 2003. He works in Dallas, TX and specializes in Clinical Pathology. Dr. Park is affiliated with Childrens Health, Parkland Memorial Hospital and William P Clements University Hospital.
Jason Park Photo 7

Jason Yongbeck Park

Specialties:
Psychiatry
Pain Medicine
Surgical Oncology
Education:
Seoul National University (1959)
Jason Park Photo 8

Jason Arthur Park

Specialties:
Surgery
Education:
University of California at Davis (1995)
Jason Park Photo 9

Jason Shinho Park, Orangeburg NY

Specialties:
Psychiatry
Work:
Rockland Children's Psychiatric Center
140 Old Orangeburg Rd, Orangeburg, NY 10962
Education:
Korea University (1963)

License Records

Jason Yong-Beck Park

Licenses:
License #: MT040542T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Jason Park resumes & CV records

Resumes

Jason Park Photo 53

Jason Park - Stamford, CT

Work:
Managers Investment Group Oct 2011 to 2000
Consultant State Street Investment Manager Solutions - Berwyn, PA Feb 2009 to Jul 2011
Senior Associate Lazard Asset Management - New York, NY May 2007 to Jan 2009
Portfolio Administrator State Street Investment Manager Solutions - Irvine, CA Oct 2004 to Apr 2007
Senior Associate State Street Bank and Trust Company - Boston, MA Sep 2003 to Sep 2004
Portfolio Administrator
Education:
New York University Jan 2008 to Dec 2011
Masters of Science in Real Estate Finance and Investment Hamilton College Sep 1998 to May 2002
Bachelor of Arts in Economics
Skills:
Proficient in Argus, Excel, Access, Word, PowerPoint, Bloomberg, Outlook, and Lotus Notes.
Jason Park Photo 54

Jason Park - Little Neck, NY

Work:
Thompson One Financial - Ithaca, NY 2008 to 2010
Equity Portfolio Manager International Business Association - Ithaca, NY 2007 to 2009
Leadership & Development Vice President of Programming Core Trading Consultants - Ithaca, NY 2006 to 2009
Student Analyst BorgWarner Morse TEC - Ithaca, NY Sep 2008 to Nov 2008
Accountant (Cooperative) Merrill Lynch - Ithaca, NY Jun 2008 to Aug 2008
Summer Analyst Mailing and contacting attendees and assisting 2008 to 2008 Core Trading Consultants - Ithaca, NY 2007 to 2008
Resident Assistant Office of International Programs - Ithaca, NY Mar 2007 to May 2007
Office Assistant K&S Construction Foundation & Nam - Flushing, NY Jun 2006 to Aug 2006
Bookkeeper
Education:
Ithaca College - Ithaca, NY Dec 2010
M.B.A. in Professional Accountancy
Skills:
Computer Skills: Experience with Thompson ONE, StockVal, TaxCut, TaxWise, QuickBooks, JD Edwards and Web Design (HTML). Advanced in Computer Hardware & Software (Microsoft Word, Excel (vlookup pivot tables),

Publications & IP owners

Us Patents

Reinforced Biologic Material

US Patent:
8333803, Dec 18, 2012
Filed:
Nov 19, 2009
Appl. No.:
12/621890
Inventors:
Jason Park - Brooklyn NY, US
Aaron Barere - Hoboken NJ, US
Christopher T. Wagner - Flemington NJ, US
Robert Kiefer - Quakertown PA, US
E. Skott Greenhalgh - Lower Gwynedd PA, US
Assignee:
Lifecell Corporation - Branchburg NJ
International Classification:
A61F 2/08
US Classification:
623 1314
Abstract:
The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.

Reinforced Biologic Material

US Patent:
2013005, Feb 28, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/616556
Inventors:
Jason Park - Brooklyn NY, US
Aaron Barere - Hoboken NJ, US
Christopher T. Wagner - Flemington NJ, US
Robert Kiefer - Quakertown PA, US
E. Skott Greenhalgh - Lower Gwynedd PA, US
International Classification:
A61F 2/08
B23P 11/00
US Classification:
623 1317, 29428
Abstract:
The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.

Methods Of Modulating Immune Activity

US Patent:
2022038, Dec 8, 2022
Filed:
May 13, 2022
Appl. No.:
17/743679
Inventors:
- Cambridge MA, US
Alexandra Masu Cantley - New York NY, US
Jason Park - West Newton MA, US
Douglas Gowers Cole - Wayland MA, US
International Classification:
A61K 31/7084
A61P 35/00
A61K 45/06
Abstract:
In one aspect, the invention provides methods of increasing immune response by administering postcellular signaling factors produced by cells exposed to a stress condition. In one aspect, the invention provides methods of increasing immune response by administering in combination (a) a Stimulator of Interferon Genes (STING) agonist and (b) a purinergic receptor agonist. The increase in immune response may be used, for example, for treatment of infection or cancer. The invention also provides screening assays for identification of compounds that induce production of postcellular signaling factors which are also immunostimulatory agents. The invention further provides methods for identifying postcellular signaling factors with immunostimulatory activity. In another aspect, the invention provides methods of decreasing immune response by administering to a cell, tissue or subject a purinergic receptor antagonist alone or in combination with a Stimulator of Interferon Genes (STING) antagonist.

Combination Anti-Cancer Therapies With Inducers Of Iron-Dependent Cellular Disassembly

US Patent:
2023011, Apr 13, 2023
Filed:
Dec 17, 2020
Appl. No.:
17/787287
Inventors:
- Cambridge MA, US
Alexandra Masu Cantley - New York NY, US
Jason Park - West Newton MA, US
Darby Rye Schmidt - Arlington MA, US
Peter Joseph Gough - Wayne PA, US
International Classification:
A61K 31/472
A61K 31/69
A61K 31/635
A61K 35/768
A61K 35/761
A61K 31/444
A61K 31/436
A61K 31/496
A61K 31/506
A61K 31/5025
A61K 31/517
A61K 31/5377
A61K 31/437
A61K 31/4545
A61K 31/519
A61K 31/502
A61K 39/395
A61K 31/4365
A61K 31/4375
A61P 35/00
Abstract:
The invention provides methods of treating a cancer in a subject, comprising administering to the subject a combination of (a) an anti-neoplastic agent and (b) an agent that induces iron-dependent cellular disassembly, thereby treating the cancer in the subject. In some embodiments, the cancer is resistant to the anti-neoplastic agent.

Methods Of Modulating Immune Activity

US Patent:
2021029, Sep 30, 2021
Filed:
May 6, 2021
Appl. No.:
17/313296
Inventors:
- Cambridge MA, US
Alexandra Masu Cantley - New York NY, US
Jason Park - West Newton MA, US
Douglas Gowers Cole - Wayland MA, US
International Classification:
A61K 31/7084
A61K 45/06
A61P 35/00
Abstract:
In one aspect, the invention provides methods of increasing immune response by administering posteellular signaling factors produced by cells exposed to a stress condition. In one aspect, the invention provides methods of increasing immune response by administering in combination (a) a Stimulator of Interferon Genes (STING) agonist and (b) a purinergic receptor agonist. The increase in immune response may be used, for example, for treatment of infection or cancer. The invention also provides screening assays for identification of compounds that induce production of postcellular signaling factors which are also immunostimulatory agents. The invention further provides methods for identifying postcellular signaling factors with immunostimulatory activity. In another aspect, the invention provides methods of decreasing immune response by administering to a cell, tissue or subject a purinergic receptor antagonist alone or in combination with a Stimulator of Interferon Genes (STING) antagonist.

Decreasing Immune Activity Through Modulation Of Postcellular Signaling Factors

US Patent:
2021028, Sep 16, 2021
Filed:
Jun 14, 2019
Appl. No.:
17/252214
Inventors:
- Cambridge MA, US
Alexandra Masu Cantley - New York NY, US
Jason Park - West Newton MA, US
International Classification:
A61K 31/245
A61K 33/04
A61K 31/45
A61K 31/095
A61K 31/137
A61K 31/277
A61K 31/353
A61K 31/407
A61K 31/122
A61K 31/381
A61K 31/355
A61K 31/202
A61K 31/05
A61K 31/085
A61K 31/499
A61K 38/12
A61K 31/16
A61K 31/4418
A61K 31/4412
A61K 49/00
A61K 31/517
A61K 31/437
A61K 31/03
A61K 31/185
A61K 31/357
A61K 31/40
A61K 31/405
A61K 31/366
A61K 31/47
A61K 31/22
A61K 31/505
A61K 31/44
A61K 31/655
A61K 33/243
A61K 38/51
A61K 33/00
A61K 33/20
A61K 33/26
A61K 31/455
A61K 31/198
A61P 37/06
A61P 35/00
G01N 33/50
Abstract:
The invention provides methods of decreasing immune response by inhibiting iron-dependent cellular disassembly. The decrease in immune response may be used, for example, for treatment of a disorder associated with iron-dependent cellular disassembly, including an autoimmune disorder, allergy, or an inflammatory disorder. The invention also provides screening assays for identification of compounds that inhibit iron-dependent cellular disassembly and are also immunoinhibitory agents.

Increasing Immune Activity Through Modulation Of Postcellular Signaling Factors

US Patent:
2021025, Aug 19, 2021
Filed:
Jun 14, 2019
Appl. No.:
17/252225
Inventors:
- Cambridge MA, US
Alexandra Masu Cantley - New York NY, US
Jason Park - West Newton MA, US
International Classification:
A61K 31/517
G01N 33/50
A61K 31/4985
A61K 31/437
A61P 35/00
A61K 45/06
Abstract:
The invention provides methods of increasing immune response by inducing iron-dependent cellular disassembly. The increase in immune response may be used, for example, for treatment of infection or cancer. The invention also provides screening assays for identification of compounds that induce iron-dependent cellular disassembly and are also immunostimulatory agents. The invention further provides methods for identifying immunostimulatory agents produced by cells undergoing iron-dependent cellular disassembly.

Vehicles For Controlled Delivery Of Different Pharmaceutical Agents

US Patent:
2020017, Jun 11, 2020
Filed:
Dec 12, 2019
Appl. No.:
16/711591
Inventors:
- New Haven CT, US
Eric Stern - Jamaica Plain MA, US
Richard A. Flavell - Guillford CT, US
Jason Park - New York NY, US
Alyssa Siefert - Naugatuck CT, US
Stephen H. Wrzesinski - Slingerlands NY, US
International Classification:
A61K 9/127
C07K 16/28
A61K 9/51
A61K 9/00
A61K 47/68
A61K 47/69
A61K 31/343
A61K 38/20
A61K 38/18
A61K 47/40
A61K 47/24
B82Y 5/00
A61K 47/58
Abstract:
A “nanolipogel” is a delivery vehicle including one or more lipid layer surrounding a hydrogel core, which may include an absorbent such as a cyclodextrin or ion-exchange resin. Nanolipogels can be constructed so as to incorporate a variety of different chemical entities that can subsequently be released in a controlled fashion. These different incorporated chemical entities can differ dramatically with respect to size and composition. Nanolipogels have been constructed to contain co-encapsulated proteins as well as small hydrophobic drugs within the interior of the lipid bilayer. Agents incorporated within nanolipogels can be released into the milieu in a controlled fashion, for example, nanolipogels provide a means of achieving simultaneous sustained release of agents that differ widely in chemical composition and molecular weight. Additionally, nanolipogels can favorably modulate biodistribution.

Possible Relatives

David C Park  Dawn M Park  Dean M Park  Dae Park  Daesun Park  Dai Park  Deborah Park  Jason F Last  Jason S Johnson  Jason R Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.